Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
1
Study Matches
Site For 18-025, EA8143 A Phase 3 Study Comparing Perioperative Nivolumab Vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy
Site For 18-025, EA8143 A Phase 3 Study Comparing Perioperative Nivolumab Vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy
Newly Diagnosed higher risk RCC of any histology No clinical or radiological evidence of distant metastases No concurrent or prior systemic or local anti-cancer therapy for RCC is permitted Age must be greater than or equal to 18 years old ECOG Performance status must be 0 or 1
Exclusion Criteria:
Women must not be pregant or breast feeding History of RCC that was resected with curative intent within the past 5 years Prior or current prostate cancer is excluded Active known or suspected autoimmune disease Uncontrolled adrenal insufficiency